Connect with us

Health

Investigational Alzheimer’s drug reduces molecular markers of the disease – News-Medical.Net

An investigational Alzheimer’s drug reduced molecular markers of disease and curbed neurodegeneration in the brain, without demonstrating…

Published

on

Article feature image

An investigational Alzheimer’s drug reduced molecular markers of disease and curbed neurodegeneration in the brain, without demonstrating evidence of cognitive benefit, in a phase 2/3 clinical trial led by researchers at Washington University School of…

Click here to view the original article.

Continue Reading
Advertisement

Trending

You might also like ...

Article feature image
Nutritional value of foods static despite targets on calories, salt and sugar – Medical Xpress
Article feature image
Vaccine general not ruling out cash bonus – Yahoo News Australia